Medicines

Japan Society for the Promotion of ScienceJP¥8.8mPatient-Centered Outcomes Research InstituteUS$6.7mNational Institute for Health and Care Research£422.6k

• Development of Novel Anti-Aging Cellular Medicines Using Designer Dental Pulp Stem Cells

  Japan Society for the Promotion of ScienceNagoya UniversityJP¥4.7m2024–2027

• Adaptive Trials of Obesity Medicines and Interventions Consortium (ATOMIC)

  National Institute for Health and Care ResearchUniversity of Cambridge£130.5k2024–2025

• Search and evaluation of bioactive constituents to reduce visceral fat accumulation obtained from natural resources utilized in traditional medicines

  Japan Society for the Promotion of ScienceKindai UniversityJP¥4.2m2022–2025

• Safer medicines To reduce falls and fractures for OsteoPorosis (#STOP)

  Medical Research Future FundUniversity of SydneyA$2.3m2021–2026

• Safer medicines To reduce falls and fractures for OsteoPorosis (#STOP)

  Department of Health, Australian GovernmentUniversity of SydneyA$2.3m2021–2026

• Comparing the Effectiveness of Four Types of Diabetes Medicines in Lowering the Risk of Heart Disease in Patients With Type 2 Diabetes And Low Or Moderate Cardiovascular Risk -- The CER-4-T2D Study

  Patient-Centered Outcomes Research InstituteBrigham and Women's HospitalUS$4.4m2021

• Comparing the Safety and Effectiveness of Metformin with Other Medicines for Patients with Type 2 Diabetes and Chronic Kidney Disease

  Patient-Centered Outcomes Research InstituteCornell UniversityUS$2.2m2018

• How do smoking cessation medicines compare with respect to their neuropsychiatric safety: a systematic review, network meta-analysis and cost effectiveness analysis.

  National Institute for Health and Care ResearchUniversity of Bristol£292.2k2016–2019